Reduction in VEGF protein and phosphorylated nephrin associated with proteinuria in adriamycin nephropathy rats

Nephron - Experimental Nephrology

Volumn 111, Issue 4, 2009, Pages

  Fan, Qingfeng ^a   Xing, Yan ^b   Ding, Jie ^a   Guan, Na ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Lisinopril; Nephrin phosphorylation; Prednisone; Proteinuria; Vascular endothelial growth factor

Indexed keywords

DOXORUBICIN; LISINOPRIL; NEPHRIN; PREDNISONE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; DOXORUBICIN; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649134882     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209209     Document Type: Article

References (27)

1. Durvasula RV, Shankland SJ: Podocyte injury and targeting therapy, an update. Curr Opin Nephrol Hypertens 2006; 15: 1-7.
2. Ronco P: Proteinuria: is it all in the foot? J Clin Invest 2007; 17: 2079-2082.
3. Ciechanowicz A, Brodkiewicz A, Binczak- Kuleta A, Parczewski M, Czekalski S: 'Treasure your exceptions': recent advances in molecular genetics of glomerular disease. J Appl Genet 2008; 49: 93-99.
4. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M, Jalanko H, Holmberg C, Tryggvason K: Nephrin is specially located at the slit diaphragm of glomerular podocytes. J Proc Nat Acad Sci USA 1999; 96: 7962-7967.
5. Huber TB, Benzing T: The slit diaphgram: a signaling platform to regulate podocyte function. Curr Opin Cell Biol 2005; 14: 211-216.
6. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621-1629.
7. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T: Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001; 276: 41543-41546.
8. Fan Q, Xing Y, Ding J, Guan N, Zhang J: The relationship among nephrin, podocin, CD2AP, and α-actinin might not be a true 'interaction' in podocyte. Kidney Int 2006; 69: 1207-1215.
9. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P: Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437.
10. Eremina V, Baelde HJ, Quaggin SE: Role of the VEGF - a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007; 106: 32-37.
11. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amorem PA: Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168: 639-648.
12. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008; 4: 39-45.
13. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP: Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69: 1654-1661.
14. Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW: Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am J Physiol Renal Physiol 2007; 292:F789-F795.
15. Wolf G, Ziyadeh FN: Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007; 106: 26-31.
16. Hara A, Wada T, Furuichi K, Sakai N, Kawachi H, Shimizu F, Shibuya M, Matsushima K, Yokoyama H, Egashira K, Kaneko S: Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int 2006; 6: 1986-1995.
17. Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S: Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006; 17: 3093-3104.
18. Xing Y, Ding J, Fan Q, Guan N: Diversities of podocyte molecules change induced by different anti-proteinuria drugs. Exp Biol Med 2006; 231: 585-593.
19. Fan L, Wakayama T, Yokoyama S, Amano O, Iseki S: Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. Nephron 2002; 90: 95-102.
20. Honkanen E, von Willebrand E, Koskinen P, Teppo AM, Törnroth T, Ruutu M, Grönhagen- Riska C: Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course. Am J Kidney Dis 2003; 42: 1139-1148.
21. Baelde HJ, Eikmans M, Lappin DW, Doran PP, Hohenadel D, Brinkkoetter PT, van der Woude FJ, Waldherr R, Rabelink TJ, de Heer E, Bruijn JA: Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 2007; 71: 637-645.
22. Kanellis J, Levidiotis V, Khong T, Cox AJ, Stacker SA, Gilbert RE, Cooper ME, Power DA: A study of VEGF and its receptors in two rat models of proteinuria. Nephron Physiol 2004; 96: 26-36.
23. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003; 284:F1263-F1273.
24. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN: Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 2005; 20:1320-1328.
25. Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ: Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288:F48-F57.
26. Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA: Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14:2063-2071.
27. Luimula P, Sandstrom N, Novikov D, Holthofer H: Podocyte associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002; 82: 713-718.